A Randomized Controlled Trial on the Efficacy of Tenofovir Disoproxil Fumarate (TDF)-Switch Therapy in Chronic Hepatitis B Patients With Incomplete Response to Entecavir
NACompletedINTERVENTIONAL
Enrollment
36
Participants
Timeline
Start Date
August 31, 2013
Primary Completion Date
January 31, 2017
Study Completion Date
January 31, 2017
Conditions
Chronic Heptitis B
Interventions
DRUG
tenofovir disoproxil fumarate
DRUG
Entecavir
Trial Locations (1)
Unknown
Prince of Wales Hospital, Hong Kong
All Listed Sponsors
lead
Chinese University of Hong Kong
OTHER
NCT01918631 - A Randomized Controlled Trial on the Efficacy of Tenofovir Disoproxil Fumarate (TDF)-Switch Therapy in Chronic Hepatitis B Patients With Incomplete Response to Entecavir | Biotech Hunter | Biotech Hunter